RESEARCH ARTICLE
B oad AOX exp ession in a gene ically ac able mouse model
does no dis u b no mal physiology
Ma en Szibo
1,2,3,
*, P a een K. Dhandapani
1,2,
*, E ic Du ou
2
, Ki a M. Holms o
m
1,2
, Yuan Zhuang
1
,
Isabelle Salwig
3
, Ilka Wi ig
4,5,6
, Juliana Heidle
4
, Zem i a Giza ullina
7
, Timu Gainu dino
7
,
Ge man Mouse Clinic Conso ium
§
, Helmu Fuchs
8
, Vale ie Gailus-Du ne
8
, Ma in H abe
de Angelis
8,9,10
,
Ja in Nandania
11
, Vidya Velagapudi
11
, As id Wie elmann
3
, Pie e Rus in
12
, F ank N. Gelle ich
7,13
,
Howa d T. Jacobs
1,2,‡,¶
and Thomas B aun
3,‡
ABSTRACT
Plan s and many lowe o ganisms, bu no mammals, exp ess
al e na i e oxidases (AOXs) ha b anch he mi ochond ial espi a o y
chain, ans e ing elec ons di ec ly om ubiquinol o oxygen wi hou
p o on pumping. Thus, hey main ain elec on low unde condi ions
when he classical espi a o y chain is impai ed, limi ing excess
p oduc ion o oxygen adicals and suppo ing edox and me abolic
homeos asis. AOX om Ciona in es inalis has been used o s udy and
mi iga e mi ochond ial impai men s in mammalian cell lines,
D osophila disease models and, mos ecen ly, in he mouse, whe e
mul iple len i ec o -AOX ansgenes con e ed subs an ial exp ession
in speci ic issues. He e, we desc ibe a gene ically ac able mouse
model in which Ciona AOX has been a ge ed o he Rosa26 locus o
ubiqui ous exp ession. The AOX
Rosa26
mouse exhibi ed only sub le
pheno ypic e ec s on espi a o y complex o ma ion, oxygen
consump ion o he global me abolome, and showed an essen ially
no mal physiology. AOX con e ed obus esis ance o inhibi o s o he
espi a o y chain in o ganello; mo eo e , animals exposed o a
sys emically applied LD50 dose o cyanide did no succumb. The
AOX
Rosa26
mouse is a use ul ool o in es iga e espi a o y con ol
mechanisms and o deciphe mi ochond ial disease ae iology in i o.
KEY WORDS: Mi ochond ia, Mi ochond ial disease, Respi a o y
chain, Al e na i e oxidase
INTRODUCTION
The mi ochond ial sys em o oxida i e phospho yla ion (OXPHOS)
comp ises ou mul isubuni complexes suppo ing s epwise
espi a o y elec on low om p ima y elec on accep o s o
oxygen, and a i h complex (ATP syn hase) ha uses he p o on
g adien he eby gene a ed ac oss he inne mi ochond ial memb ane
o syn hesize ATP. In many lowe o ganism and plan s, al e na i e
oxidases (AOXs) a e exp essed ha b anch he mi ochond ial
espi a o y chain, hus ans e ing elec ons di ec ly om ubiquinol
o oxygen in a non-p o on-mo i e manne . AOXs a e absen in
mammals (Young e al., 2013) (Fig. 1A). Thei main physiological
ole is o main ain elec on low unde condi ions when he classical
espi a o y chain is impai ed, limi ing excess p oduc ion o oxygen
adicals and suppo ing edox and me abolic homeos asis. Because
AOX is also ound in some in e eb a e phyla (McDonald e al.,
2009), we ha e p oposed ha i s exp ession in commonly s udied
animal models could be used o elucida e he pa hophysiology
unde lying mi ochond ial OXPHOS diso de s, p o iding a a ional
basis o i s e en ual implemen a ion in he apeu ic applica ions
(Rus in and Jacobs, 2009; El-Khou y e al., 2014).
In ea lie s udies, AOX om he unica e Ciona in es inalis,a
sis e g oup o he e eb a es, was shown o be exp essible and
ca aly ically ac i e in human cells (Hakkaa e al., 2006). I was
ound o alle ia e he dele e ious consequences o oxic o
pa hological inhibi ion o he downs eam po ion o he
mi ochond ial espi a o y chain (Hakkaa e al., 2006; Dassa
e al., 2009), speci ically OXPHOS complexes III (cIII) and IV
(cIV), which AOX bypasses. A cDNA encoding Ciona AOX was
subsequen ly shown o be ubiqui ously exp essible in D osophila,
wi hou elici ing any ha m ul pheno ypic e ec s (Fe nandez-Ayala
e al., 2009). In he ly, AOX exp ession was able o compensa e a
ange o pa hological pheno ypes a he whole-o ganism le el,
including le hali y caused by OXPHOS poisons such as an imycin
A o cyanide (Fe nandez-Ayala e al., 2009), locomo o dis u bance
o neu odegene a ion caused by cIV knockdown (Kemppainen
e al., 2014) o o he causes o neu odegene a ion mimicking
Pa kinson’s (Fe nandez-Ayala e al., 2009; Humph ey e al., 2012)
o Alzheime ’s (El-Khou y e al., 2016) diseases.
The po en ial o using AOX o s udy mi ochond ial
pa hophysiology a he whole-o ganism le el in mammals has been
demons a ed using len i ec o ansduc ion, c ea ing a ansgenic
mouse exp essing Ciona AOX in mul iple issues (El-Khou y e al.,
2013). No ably, ha m ul pheno ypes we e again no seen, despi e
widesp ead ansgene exp ession. Howe e , he me hodological
issues a ising om he na u e o ha model ha e p ecluded i s
widesp ead use. On inse ion o AOX ansgenes a mul iple genomic
si es in he model, none o hem indi idually con e ed exp ession a a
high le el o in all issues. Thus, he model could no be combined
Recei ed 14 Sep embe 2016; Accep ed 30 No embe 2016
1
Ins i u e o Bio echnology, FI-00014 Uni e si y o Helsinki, Finland.
2
BioMediTech
and Tampe e Uni e si y Hospi al, FI-33014 Uni e si y o Tampe e, Finland.
3
Max
Planck Ins i u e o Hea and Lung Resea ch, Ca diac De elopmen and
Remodelling (Depa men I), Bad Nauheim D-61231, Ge many.
4
Func ional
P o eomics, SFB 815 Co e Uni , Facul y o Medicine, Goe he-Uni e si y, F ank u am
Main D-60590, Ge many.
5
Ge man Cen e o Ca dio ascula Resea ch (DZHK),
Pa ne si e RheinMain, F ank u , Ge many.
6
Clus e o Excellence “Mac omolecula
Complexes”, Goe he-Uni e si y, F ank u am Main D-60590, Ge many.
7
Leibniz
Ins i u e o Neu obiology, Magdebu g D-39118, Ge many.
8
Ge man Mouse Clinic,
Ins i u e o Expe imen al Gene ics, Helmhol z Zen um Mu
nchen, Ge man Resea ch
Cen e o En i onmen al Heal h GmbH, Ingols aed e Lands asse 1, Neuhe be g
85764, Ge many.
9
Chai o Expe imen al Gene ics, Cen e o Li e and Food Sciences
Weihens ephan, TU Munich, Emil-E lenmeye -Fo um 2, F eising-Weihens ephan
85350, Ge many.
10
Membe o Ge man Cen e o Diabe es Resea ch (DZD),
Ingols aed e Lands asse 1, Neuhe be g 85764, Ge many.
11
Ins i u e o Molecula
Medicine Finland, FI-00014 Uni e si y o Helsinki, Finland.
12
INSERM UMR 1141 and
Uni e si ePa is 7, Ho
pi al Robe Deb e, Pa is 75019, F ance.
13
Depa men o
Neu ology, O o- on-Gue icke-Uni e si y, Magdebu g D-39120, Ge many.
*These au ho s con ibu ed equally o his wo k.
‡
These au ho s sha e senio au ho ship.
§
A ull lis o conso ium membe s appea s in Supplemen a y in o ma ion
¶
Au ho o co espondence (howa d.jacobs@helsinki. i)
T.G., 0000-0003-1723-1780; H.T.J., 0000-0003-1895-6003
This is an Open Access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion
License (h p://c ea i ecommons.o g/licenses/by/3.0), which pe mi s un es ic ed use,
dis ibu ion and ep oduc ion in any medium p o ided ha he o iginal wo k is p ope ly a ibu ed.
163
© 2017. Published by The Company o Biologis s L d
|
Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
wi h gene ic disease models o o he mouse mu an s, could no be
p ac ically ans e ed in o o he s ain backg ounds, and i s long- e m
main enance was essen ially impossible.
He e, we epo he c ea ion o a gene ically ac able ansgenic
mouse ha ubiqui ously exp esses a single copy o Ciona AOX a
subs an ial le els, a e a ge ed inse ion in o he Rosa26 locus. The
Rosa26 knock-in ga e ise o a unc ional enzyme, which con e ed
esis ance o espi a o y poisons. Su p isingly, comp ehensi e
pheno yping e ealed only mino , biologically inconsequen ial
e ec s o AOX exp ession in he AOX
Rosa26
mouse. The new model
o e s g ea p omise as a ool o elucida ing he mechanisms o
mi ochond ial pa hology and cha ing heway owa ds u u e he apies.
RESULTS
Cons uc ion o AOX
Rosa26
mice
To c ea e a gene ically ac able mouse model ubiqui ously
exp essing Ciona AOX, we used gene a ge ing in o he
ubiqui ously ac i e Rosa26 locus (Hi oshi e al., 1991) in
mouse emb yonic s em cells (ESC) (So iano, 1999; S ini as
e al., 2001). P e ious au ho s ha e epo ed no de ec able
pa hological al e a ions a ising om inse ions a his locus
(F ied ich and So iano, 1991; Zamb owicz e al., 1997), and
ansgene exp ession seems o be s able (Zamb owicz e al.,
1997). To boos exp ession om he Rosa26 locus, we
inco po a ed he syn he ic CAG enhance -p omo e in o he
cons uc (Fig. 1B; Fig. S1), which enhances exp ession se e al-
old (Nyabi e al., 2009; Chen e al., 2011). A e e i ica ion
o he inse ion in ESCs by Sou he n blo ing (Fig. S1B,C),
a chime ic line was es ablished ia blas ocys injec ion, wi h
subsequen elimina ion o he posi i e-selec able (neomycin
esis ance) casse e (Fig. S1A,B) by Flp ecombina ion in i o,
ollowing ge m-line ansmission. Founde s we e backc ossed
o e mo e han se en gene a ions o s ain C57Bl/6J, wi h
ansgene p esence checked a each s ep by PCR (Fig. S1D). The
a e o ansmission o he AOX ansgene om he e ozygous
pa en s o ei he sex did no signi ican ly de ia e om 50%
(Fig. 1C), no was he e any signi ican pa en -o -o igin e ec on
li e size (Fig. 1C). The p ogeny sex a io was also una ec ed by
he AOX ansgene (Fig. 1D).
AOX is ubiqui ously exp essed in he AOX
Rosa26
mouse
No he n blo ing (Fig. 1E) con i med widesp ead, hough somewha
une en, exp ession wi h highes AOX mRNA le els in hea and
skele al muscle, bu lowe exp ession in b ain, aking accoun o he
Fig. 1. Cons uc ion and cha ac e iza ion o AOX
Rosa26
mice. (A) Schema ic diag am o he mi ochond ial OXPHOS sys em, showing he i e s anda d
OXPHOS complexes (I-V), he di usible elec on ca ie s ubiquinone (Q) and cy och ome c (c), and he passage o elec ons and p o ons esul ing ul ima ely in
he syn hesis o ATP om ADP and ino ganic phospha e (Pi). The addi ional p esence o AOX, whe he supplied ansgenically o in o ganisms na u ally endowed
wi h i , p o ides an al e na i e ou e o he eoxida ion o ubiquinol by molecula oxygen, wi hou p o on pumping. (B) Schema ic diag am o inse ed Rosa26-AOX
exp ession cons uc , ollowing emo al o addi ional elemen s (i.e. DTA nega i e selec able ma ke upon a ge ed in eg a ion, and neomycin esis ance casse e
ollowing FRT-media ed excision in i o). Remaining elemen s a e he CAG p omo e , AOX coding sequence and β-globin in on and poly(A) addi ion signal
(βGi+pA). Fo ull de ails see Fig. S1A. (C) T ansmission a e o AOX ansgenes (based on PCR) and li e sizes, acco ding o sex o AOX-hemizygous pa en .
T ansmission a es om male (n=93, 12 c osses) and om emale (n=43, 6 c osses) we e no signi ican ly di e en om each o he (S uden ’s - es , P>0.05,
mean±s.d.) o om Mendelian expec a ion o 50% (chi-squa ed es ). Li e sizes p oduced by AOX-hemizygous males and emales also showed no signi ican
di e ence (S uden ’s - es , P>0.05). (D) Sex (% o males) o ansgenic and wild- ype p ogeny o hemizygous AOX
Rosa26
mice (n=136, 18 c osses), again
showing no signi ican di e ences (S uden ’s - es , P>0.05, mean±s.d.). (E) No he n blo showing AOX exp ession in RNA (10 μg) om issues o one-yea -old,
male, hemizygous AOX
Rosa26
mice and wild- ype (w ) li e ma e con ols: He, hea ; Lu, lung; Li, li e ; B , b ain; Ki, kidney; Sp, spleen; Te, es is; Sk, skele al
muscle. The blo was ep obed o A p5b mRNA as well as mi ochond ial 12S and cy osolic 18S RNAs as loading con ols. RNA molecula weigh s we e
ex apola ed om RNA mig a ion in he e hidium b omide-s ained gel.
164
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
loading con ols. A he p o ein le el, exp ession seemed mo e
uni o m, bu was again highes in hea , skele al muscle and panc eas,
and lowes in b ain (Fig. 2A; Fig. S2). B ain exp ession was highes in
newbo n mice (Fig. S2C), bu declined subs an ially by one mon h o
age (Fig. S2C). As expec ed, AOX exp ession was highe in
homozygo es compa ed wi h he e ozygous animals (Fig. S2D). The
enzyme was ound o be associa ed wi h he memb ane ac ion o
isola ed mi ochond ia a e ca bona e ex ac ion (Fig. S2E), albei less
igh ly bound han some in eg al memb ane p o eins o he OXPHOS
complexes, such as subuni 1 o cIV (M co1).
In each issue es ed, he exp ession o ep esen a i e subuni s
o he i e OXPHOS complexes was essen ially una ec ed by
AOX exp ession (Fig. 2A; Fig. S2A). Mo eo e , he o e all
s uc u e o he espi a o y memb ane, speci ically i s o ganiza ion
in o supe complexes, was simila ly unal e ed, based on blue-na i e
elec opho esis (BNE) ollowed by in-gel his ochemis y o hea
mi ochond ia (Fig. 2B), and on BNE combined wi h wes e n blo s
o OXPHOS subuni s, o eigh di e en issues (Fig. S2F). In BNE
gels, AOX i sel mig a ed mainly a he size o a dime and as
mul ime s he eo (Fig. S2F,G), a he han associa ing speci ically
wi h any o he espi a o y complex. In each issue es ed, he
mobili y o he espi a o y chain complexes de ec ed by BNE was
iden ical o ha in con ols (Fig. S2F). P incipal componen analysis
o me aboli e le els in skele al muscle (Fig. 2C) and hea
(Fig. S2H) showed no consis en e ec o AOX exp ession, no
did any o 100 indi idual me aboli es analyzed show any signi ican
di e ence (Tables S1, S2).
AOX is unc ional in AOX
Rosa26
mice
We conduc ed espi ome y o de e mine whe he AOX is
enzyma ically unc ional in he AOX
Rosa26
knock-in mice.
Mi ochond ia om six issues (Fig. 3) we e es ed in a s anda d
p o ocol o oxygen consump ion in he p esence o complex I-, II-
and IV-linked subs a es, successi ely using inhibi o s o cI
( o enone), cIII (an imycin A), AOX (n-p opyl galla e) and cIV
(cyanide o azide). The e we e no signi ican di e ences when oxygen
consump ion was compa ed wi h ha om mi ochond ia o wild- ype
li e ma es, excep o subs a e oxida ion in he p esence o an imycin
A (i.e. media ed by AOX), which was signi ican o all issues es ed
excep b ain, whe e exp ession was low. Mi ochond ia om issues
o AOX
Rosa26
mice o he han b ain showed an imycin A- esis an
(AOX-dependen ) oxygen consump ion be ween 30% and 70% o
he uninhibi ed le el d i en by succina e (Fig. 3A), simila also o
p elimina y measu emen s in he ounde mouse (Fig. S3A). In hea
mi ochond ia om AOX-exp essing compa ed wi h con ol mice,
an imycin A- and azide- esis an subs a e oxida ion was e iden
ac oss a wide ange o d ug concen a ions (Fig. S3B). Compa ed
wi h li e ma e con ols, mi ochond ial ROS p oduc ion d i en by
succina e was g ea ly dec eased (Fig. 3B). In e es ingly, his was only
signi ican in he absence o o enone, implica ing AOX in p o iding
Fig. 2. AOX
Rosa26
mice show b oad AOX exp ession and no mal me abolism. (A) Wes e n blo s o 20 μg o al p o ein ex ac s om he indica ed issues (He,
hea ; Tm, high muscle; Mm, masse e muscle; Pa, panc eas; Lu, lung; Li, li e ; Ki, kidney; Sp, spleen; Ce, ce eb um; Cb, ce ebellum; Sg, sali a y gland; Te,
es is) o 54-week-old male hemizygous AOX
Rosa26
(+) and wild- ype li e ma e con ol (–) mice, p obed o AOX and o ep esen a i e subuni s o he i e
OXPHOS complexes (see Ma e ials and Me hods, p o ein molecula weigh s ex apola ed om ma ke s). Fo Ponceau S s aining o he memb anes see
Fig. S2B. See also Fig. S2A,C,D. (B) BNE gels o mi ochond ial memb ane p o eins om hemizygous AOX
Rosa26
(+) and wild- ype li e ma e con ol (–) mice,
s ained wi h Coomassie Blue (CB) o p obed by in-gel his ochemis y o he indica ed OXPHOS complexes. * deno es he mig a ion o he espec i e monome ic
complexes. Assignmen o mi ochond ial complexes (I, cI; III
2
, dime ic cIII; IV, cIV; V, cV; S
1
, espi a o y supe complexes con aining cI, dime ic cIII and one copy o
cIV) is based on p o ein molecula weigh s ex apola ed om he mig a ion o he complexes om bo ine hea mi ochond ia, whose subuni composi ion is
known. (C) P incipal componen analysis o me abolome da a om skele al muscle o hemizygous AOX
Rosa26
( ed ci cles) and wild- ype li e ma e con ol mice
(g een ci cles). The wo se s o analysed da a o e lap, apa om wo mino ou lie s om he con ol g oup. See also Fig. S2H.
165
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
an al e na i e pa hway o succina e oxida ion o he han e e se
elec on anspo h ough cI.
AOX
Rosa26
mice exhibi no mal physiology
The high le el o AOX exp ession, capable o eplacing a la ge
ac ion o elec on low when cIII/IV is inhibi ed, aised he ques ion
o po en ially dele e ious consequences unde no mal physiological
condi ions. Su p isingly, AOX
Rosa26
mice o bo hsexes we e simila in
size o li e ma e con ols and gained weigh no mally du ing
de elopmen (Fig. 4A). Muscle and hea unc ions showed no
signi ican di e ences om li e ma e con ols, based on s anda d
assays o g ip s eng h (Fig. 4B), eadmill pe o mance (Fig. 4B),
ca diac ejec ion ac ion (Fig. 4C) and le en icula mass (LVM;
Fig. 4C), conduc ed on mice o di e en ages. To complemen hese
da a we implemen ed a comp ehensi e pheno yping, using he
esou ces o he Ge man Mouse Clinic (h ps://www.mouseclinic.de,
sea ch ‘phenomap’; he ea e e e ed o as ‘GMC Phenomap’). This
analysis co e ed me abolic, beha iou al, mo phological,
immunological, ca diac and neu ological pa ame e s, amongs
o he s. None o he pa ame e s es ed showed subs an ial o
sys ema ic de ia ions om li e ma e con ols.
AOX con e s p o ec ion agains an LD50 dose o sys emically
deli e ed cyanide
Despi e he absence o any meaning ul pheno ype unde s anda d
(non-s ess ul) physiological condi ions, we easoned ha he
ubiqui ous exp ession (Fig. 2) o unc ional AOX (Fig. 3) should
con e whole-o ganism esis ance o a espi a o y poison a ge ing
cIII o cIV. Sample coho s o emale mice we e hus es ed o hei
esponse o sys emically adminis e ed po assium cyanide a ∼LD50
(Yamamo o, 1995), wi h e alua ion o su i al a e 1, 24 and 48 h.
All i e AOX
Rosa26
ansgenic mice es ed su i ed he ea men ,
whe eas h ee o six li e ma e con ols succumbed as expec ed
(Fig. 5). Al hough he sample sizes a e small, hence indica i e a he
han de ini i e, he esul is consis en wi h p o ec ion agains
cyanide a he whole-o ganism le el.
DISCUSSION
In his s udy we success ully enginee ed mice o s able, ubiqui ous
exp ession o Ciona AOX, ia a single-copy inse ion in o he
Rosa26 locus, con olled by he syn he ic CAG p omo e . AOX
p o ein was widely exp essed and enzyma ically unc ional when
es ed in he p esence o an imycin A in o ganello. AOX exp ession
p oduced negligible pheno ypic e ec s unde s anda d physiological
condi ions, bu seemed able o p o ec mice om he le hal e ec s o
injec ed cyanide. The AOX
Rosa26
mouse p o ides a gene ically
ac able ool o analyzing he pa hophysiology o a wide spec um
o diseases p oposed o be linked o mi ochond ial espi a o y
dys unc ion.
The AOX
Rosa26
mouse is a gene ically ac able model
The ‘Mi AOX’ ansgenic mice, p e iously gene a ed by len i ec o
ansduc ion (El-Khou y e al., 2013), p o ided a p elimina y
indica ion ha widesp ead Ciona AOX exp ession in he mouse is
no ha m ul. Howe e , owing o he mul i-copy na u e o he
inse ed ansgene a di e en genomic si es, as well as a ying
exp ession le els, Mi AOX mice we e no sui able o s udies using
gene ic disease models. To a oid hese p oblems, we c ea ed a
e ised model con aining a single inse ion o AOX cDNA a he
Rosa26 locus on ch omosome 6. We demons a ed (Fig. 1) ha he
Fig. 3. AOX is enzyma ically unc ional in mi ochond ia om AOX
Rosa26
mice. (A) Respi ome y (oxygen consump ion in he indica ed uni s) om isola ed
mi ochond ia p epa ed om he indica ed issues o hemizygous AOX
Rosa26
mice and wild- ype li e ma e con ols, as shown; means±s.d. o h ee biological
eplica es in each case. No e he di e en scales. 1 (Mal) – o enone-sensi i e oxida ion o mala e in he p esence o glu ama e, py u a e and ADP; 2 (Succ) –
an imycin A- plus n-p opyl galla e-sensi i e succina e oxida ion; 3 (AOX) – a e o n-p opyl galla e-sensi i e, an imycin A-insensi i e succina e oxida ion;
4 (TMPD) – a e o asco ba e- educed TMPD oxida ion. Fo u he de ails see Ma e ials and Me hods. See Fig. S3C o espi a o y con ol a io in hese samples.
(B) ROS p oduc ion, measu ed as H
2
O
2
ou pu , om hea mi ochond ia o AOX
Rosa26
mice and wild- ype li e ma es, as indica ed, d i en by he indica ed
subs a es o inhibi o s (succ, succina e; o , o enone; py , py u a e; mal, mala e).
#
P<0.05 o *P<0.001 be ween gi en pai s o con ol and AOX
Rosa26
alues,
S uden ’s - es , means±s.d. No e ha i is no possible o e i y ha his e ec depends on he enzyma ic ac i i y o AOX, because he AOX inhibi o , n-p opyl
galla e, is i sel a po en an ioxidan .
166
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
in oduced AOX gene is s ably ansmi ed in a Mendelian manne ,
emains ac i e beyond a leas se en gene a ions o backc ossing o
s ain C57Bl/6J, shows no pa en -o -o igin o sex-speci ic le hali y,
and is widely exp essed. The AOX ansgene can, in p inciple, be
ans e ed o any desi ed s ain backg ound sui able o
combina ion wi h a gi en gene ic model o disease, al hough ou
cu en analysis was con ined o he C57Bl/6J gene ic backg ound.
We expec ha he AOX
Rosa26
mouse will become a e sa ile model
o s udying he na u e o mi ochond ial in ol emen in disease-like
pheno ypes.
AOX seems ine unde s anda d physiological condi ions
Al hough AOX was enzyma ically unc ional in he p esence o
an imycin A in o ganello, ou da a indica e ha he me azoan
enzyme is unc ionally ine unde s anda d physiological
condi ions, as sugges ed p e iously (Hakkaa e al., 2006;
Fe nandez-Ayala e al., 2009; El-Khou y e al., 2013). Se e al
lines o e idence suppo his conclusion: (1) any subs an ial
con ibu ion by he non-p o on-mo i e AOX o espi a o y elec on
low should mani es in a signi ican ly dec eased espi a o y con ol
a io in espi ome ic measu emen s in o ganello. Howe e , we did
no obse e any signi ican al e a ion in ou issue su ey a leas o
cI-linked subs a es and wi hin he de ec ion limi s o he me hod
applied (Fig. S3C). (2) Ine icien mobiliza ion o nu i ional
esou ces by AOX-exp essing mice should al e me abolic
pa ame e s in i o. Howe e , he e we e no di e ences in whole
body weigh (Fig. 4A), a o lean body mass de e mined by
nuclea magne ic esonance (NMR) (see GMC Phenomap),
o physiological pa ame e s de e mined by indi ec calo ime y,
including ood in ake, body empe a u e, oxygen/CO
2
exchange o
ac i i y (see GMC Phenomap). (3) No signi ican di e ences in
hea pe o mance we e de ec ed by elec o- o echoca diog aphy, o
MRI (Fig. 4C; GMC Phenomap), al hough he hea is he mos
ene gy-demanding issue and showed he highes AOX exp ession.
Low AOX exp ession in b ain
The ela i ely low exp ession o he AOX ansgene in adul b ain
(Fig. 1E, Fig. 2A, Fig. S2A,D) is somewha puzzling, gi en
p e ious epo s. The CAG p omo e has p e iously been used o
d i e ansgene exp ession a a high le el in he mouse b ain du ing
de elopmen (Liu e al., 2014) as well as in he adul (Ida-
Hosonuma e al., 2002; Kim e al., 2013), and he Rosa26 locus
e icien ly d i es exp ession in he b ain (Bana es e al., 2005; Hi z
e al., 2007; Delaunay e al., 2009). Mo eo e , we also achie ed
subs an ial exp ession in he b ains o Mi AOX ansgenic mice
(El-Khou y e al., 2013), using he same CAG p omo e .
Fig. 4. AOX
Rosa26
mice exhibi no mal physiology. (A) Mean weigh ±s.d. o hemizygous AOX
Rosa26
and wild- ype li e ma e con ol mice o he sexes indica ed,
du ing pos -na al de elopmen , n≥8 o each sex and geno ype analysed. (B) Muscle pa ame e s o male hemizygous AOX
Rosa26
and wild- ype li e ma e con ol
mice o he ages indica ed; means±s.d. Fo each g oup analysed n≥4 (g ip s eng h) o n≥6 ( eadmill). (C) Ca diac pa ame e s, as indica ed, o hemizygous
AOX
Rosa26
and wild- ype li e ma e con ol mice o he sex and ages indica ed; means±s.d., n≥4 o each g oup analysed. All da a ob ained by echoca diog aphy
excep ejec ion ac ion a 10 w o age, which used MRI, n≥5. The e we e no signi ican di e ences be ween AOX
Rosa26
and wild- ype alues o any pa ame e
measu ed (S uden ’s - es , P>0.05).
Fig. 5. Sampled AOX
Rosa26
mice a e p o ec ed agains cyanide oxici y
in i o.Su i al cu es o samples o hemizygous emale AOX
Rosa26
mice
(n=5) and wild- ype con ols (n=6) ea ed sys emically wi h KCN as desc ibed
in Ma e ials and Me hods. No e ha he expe imen would need o be
conduc ed on a much g ea e scale o gene a e ully eliable s a is ics, bu is
p ecluded by e hical conside a ions.
167
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms

In iguingly, neona al AOX
Rosa26
b ains exp essed subs an ially
mo e AOX a he p o ein le el han adul s (Fig. S2C), indica ing ha
he ansgene can be ac i e, bu appa en ly egula ed, in neu al cells.
A p esen we do no ha e a con incing explana ion o hese
anomalies. Howe e , he ela i ely low exp ession o AOX in he
adul b ain seemed su icien o p o ec agains he le hali y o
sys emically deli e ed cyanide (Fig. 5), which can c oss he blood-
b ain ba ie and has majo oxic e ec s in he cen al ne ous
sys em (Yamamo o and Tang, 1996; Rei e e al., 2010; Zhang e al.,
2015). I will be in e es ing o explo e in g ea e dep h he speci ic
physiological e ec s o his dose o cyanide and how hese e ec s
a e modi ied by AOX exp ession.
Lack o me abolic dis u bance esul ing om AOX
exp ession
The lack o any disce nible, dele e ious pheno ype a he whole-
o ganism le el a ising om AOX exp ession (Fig. 4; supplemen a y
Da a), mi o s he lack o biochemical dis u bance in he AOX
Rosa26
mouse. This was he case e en in hea (Fig. 2A,B) and skele al
muscle (Fig. 2A) issues showing high le els o AOX exp ession.
The highly p o einaceous inne mi ochond ial memb ane is
o ganized in o di e en subcompa men s wi h dis inc s uc u es,
p o ein composi ion and biochemical unc ions (Vogel e al., 2006).
In pa icula , he sup amolecula o ganiza ion o he OXPHOS
sys em in supe complexes is gene ally conside ed o maximize he
e iciency o elec on low (Acín-Pé ez e al., 2008; Chaban e al.,
2014). We obse ed no s uc u al (Fig. 2B) o unc ional (Fig. 3A)
dis u bance o he endogenous espi a o y memb ane upon AOX
exp ession, which migh e lec na u al p ope ies o Ciona AOX,
enabling i o eside in he mi ochond ia o i s pa en species.
T ansgenic AOX seems o o m homome ic complexes, a he han
associa ing wi h (and po en ially dis up ing) o he OXPHOS
complexes. The elec opho e ic mobili y o he s anda d
OXPHOS complexes was indis inguishable om ha in con ols,
in all issues es ed (Fig. 2B; Fig. S2F,G). Ou indings imply ha
hese mul ime s a e hemsel es benign, al hough i emains
unknown whe he AOX is s uc u ally a ayed in a simila manne
in i s na u al con ex in Ciona. We eason ha , by emaining
uncomplexed wi h o he espi a o y chain componen s, he enzyme
would be unc ionally adap ed o ac as a sink o elec ons
ans e ed om di usible quinols in he inne mi ochond ial
memb ane. Quinone educ ion migh a ise om he ope a ion o
di e se dehyd ogenases, including, o example, cII, elec on
ans e ing la op o ein dehyd ogenase, he mi ochond ial
iso o m o glyce ol-3-phospha e dehyd ogenase and
dihyd oo o a e dehyd ogenase. Unde no mal physiological
condi ions, di usible quinols would be e icien ly mopped up by
(dime ic) cIII, whe he alone o a ached o cIV as a supe complex.
As in plan s (Hoe nagel and Wiskich, 1998; Cas o-Gue e o e al.,
2004), AOX would only become ac i e a high quinol
concen a ions, e lec ing i s lowe a ini y o quinols han cIII.
Thus, AOX would be b ough in o play only when quinols
accumula e as a esul o inhibi ion o o e load o he s anda d
espi a o y pa hway, as in e ed p e iously in human cells (Dassa
e al., 2009). This hypo hesis is also consis en wi h ou obse a ion
ha AOX exp ession d as ically dec eases mi ochond ial ROS
p oduc ion by hea mi ochond ia in he p esence o high le els o
succina e (Fig. 3B), which p omo es e e se elec on low h ough
cI (Chouchani e al., 2014). Ou obse a ions sugges ha AOX
migh ha e d ama ic consequences unde s ess, especially in hea
and o he issues whe e i is highly exp essed. Tes s o his
hypo hesis will also e eal whe he AOX could ha e bene icial oles
in u u e he apies (El-Khou y e al., 2014). A i s demons a ion o
he u ili y o AOX
Rosa26
mice has ecen ly been published (Mills
e al., 2016), in which AOX was shown o con e esis ance agains
le hali y in models o bac e ial sepsis. Fu he ials, combining
AOX
Rosa26
wi h speci ic gene ic disease models, should e eal he
ex en o which AOX can alle ia e he pa hophysiology o
espi a o y chain dys unc ion. The AOX
Rosa26
mouse model
should ha e wide applica ions and is a ailable o he esea ch
communi y, upon eques .
MATERIALS AND METHODS
Cons uc ion o a ge ing ec o
S anda d cloning and ecombinee ing p ocedu es (Liu e al., 2003; Wa ming
e al., 2005) we e used o assemble he pRosa26-Aox a ge ing ec o .
B ie ly, PL451 was adap ed o se e as AOX en y ec o , by in eg a ing
homology a ms o he mouse Rosa26 locus (PL451-Rosa26) ups eam and
downs eam o he neomycin selec ion casse e. Ciona AOX (Hakkaa
e al., 2006) was in eg a ed ups eam o he selec ion casse e, and used o
co- ans o m ecombinee ing-compe en Esche ichia coli (EL250) wi h a
Rosa26- a ge ing plasmid (pRosa26-DTA). Posi i e clones we e selec ed
by kanamycin esis ance (pRosa26-Aox), e i ied by PCR and sequencing,
and elec opo a ed in o 6.5 ESCs ollowing linea iza ion wi h SalI. A e
nega i e (DTA, Dip he ia oxin A) and posi i e (G418) selec ion,
homologous in eg a ion was e i ied by Sou he n blo ing (Koe sie e al.,
1993) using gene-speci ic es ic ion enzymes and p obes o dis inguish he
wild- ype and manipula ed alleles (see supplemen a y Ma e ials and
Me hods and Fig. S1B,C o u he de ails).
C ea ion o ansgenic mice
ESC clones posi i e o in eg a ion we e injec ed in o blas ocys s and
ans e ed o pseudop egnan mice. Chime ic males we e hen backc ossed
on o he C57Bl/6J s ain backg ound o gene a e he e ozygous animals, and
subsequen ly b ed wi h mice ubiqui ously exp essing FLP ecombinase
(Rod íguez e al., 2000), in o de o dele e he neomycin selec ion casse e.
Mice we e backc ossed (>7 gene a ions) o C57Bl/6J emales o ob ain a
clean gene ic backg ound o all subsequen s udies.
PCR geno yping o AOX
Rosa26
mice
C ude DNA o geno yping was ex ac ed om ea punches o ail cu s by
s anda d me hods (p o einase K ea men , isop opanol p ecipi a ion and
o e nigh esuspension in TE a 56°C). Mul iplex PCR geno yping was ca ied
ou using p ime s Aox 317 s: 5′-GCGATGCAAGATGGAGGGTA-3′plus
Aox 317 as: 5′-TGAATCCAACCGTGGTCTCG-3′ o AOX, and Rosa26_w
s: 5′-GACCTCCATCGCGCACTCCG-3′plus Rosa26_w as: 5′-
CTCCGAGGCGGATCACAAGC-3′ o he wild- ype Rosa26 locus, gi ing
espec i e p oduc s o 317 and 523 bp. PCR eac ions o 20 μlcon ained
4 pmol o each p ime , DMSO a 2% and 0.2 μl DyNazyme II (The mo Fishe
Scien i ic), wi h cycle pa ame e s o ini ial dena u a ion a 95°C o 5 min, hen
39 cycles o dena u a ion a 95°C o 20 s, annealing a 56°C o 30 s and
ex ension a 72°C o 60 s, wi h inal ex ension s ep a 72°C o 10 min,
ollowed by 1.5% aga ose gel elec opho esis. See Fig. S1D o example gel.
RNA analysis
RNA was p epa ed om dissec ed mouse issues by bead homogeniza ion in
700 μl (>10 olumes) o T izol eagen (Sigma). A e incuba ion o 5 min
a oom empe a u e, samples we e gen ly ex ac ed wi h 0.2 olumes o
chlo o o m and cen i uged a 12,000 g
max
o 15 min a 4°C. The uppe
(aqueous) phase was decan ed and RNA eco e ed by isop opanol
p ecipi a ion and cen i uga ion. Using s anda d p ocedu es (Samb ook
e al., 1989), ai -d ied RNA pelle s we e esuspended in 20 μl RNase- ee
wa e , ac iona ed on o maldehyde-aga ose gels, blo ed o Hybond-N+
memb ane (GE Heal hca e) in 10×SSC and hyb idized o end-labelled DNA
oligonucleo ide p obes o AOX, mi ochond ial 12S and cy osolic 18S
RNA, and A p5b mRNA, espec i ely 5′-CTTGACCCACTGTTTCTCA-
TCTAGCCG-3′,5′-CATGGGCTACACCTTGACCT-3′,5′-TCGAACCC-
TGATTCCCCGTCACCC-3′and 5′-GGTGAATATGACCATCTCCCAG-
AACAAGC-3′.
168
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
P o ein analysis
Fo p o ein ex ac ion, small pieces o esh o ozen issue om dissec ed
o gans we e placed in 500 μl o lysis bu e (50 mM T is/HCl, 150 mM
NaCl, 1 mM EDTA, 1% T i on X-100, pH 7.4), con aining a dissol ed
p o ease inhibi o cock ail able (Pie ce), in a 5 ml ube on ice. A e
homogeniza ion using a POLYTRON PT 1200 E Manual Dispe se
(Ecoline), samples we e incuba ed on ice o 30 min ollowed by
cen i uga ion a 14,000 g
max
o 5 min a 4°C. Supe na an s we e sa ed
and p o ein concen a ion was measu ed using B ad o d eagen (Bio-Rad)
be o e dilu ion in o SDS-PAGE sample bu e o elec opho esis on SDS
12% polyac ylamide gels. A e semi-d y ans e o PROTRAN
ni ocellulose memb anes (Pe kinElme ), wes e n blo s we e p obed using
p ima y an ibodies o AOX [cus omized abbi an ibody, 21s Cen u y
Biochemicals (Fe nandez-Ayala e al., 2009), 1:40,000 in T is-bu e ed
saline (TBST) con aining 5% BSA] wi h seconda y an ibody pe oxidase-
conjuga ed A iniPu e goa an i- abbi IgG (Jackson ImmunoResea ch,
111-035-144, 1:20,000). A e s ipping by wo 20 min washes wi h
100 mM β-me cap oe hanol, 2% SDS, 62.5 mM T is-HCl (pH 6.7), each
ollowed by blocking wi h TBST con aining 5% milk o 30 min, blo s we e
ep obed o ep esen a i e subuni s o he OXPHOS complexes, using
To al OXPHOS Cock ail an ibody [Abcam, ab110413, 1:250; isualizing
Sdhb (cII), Uqc c2 (cIII), M co1 (cIV) and A p5a (cV)], plus an an ibody
agains complex 1 subuni Ndu s3 (Mi osciences, ab14711, 1:4000), bo h
de ec ed wi h pe oxidase-conjuga ed A iniPu e goa an i-mouse IgG
(Jackson ImmunoResea ch, 115-035-146, 1:1000) as seconda y an ibody.
Chemiluminescen de ec ion used 20× LumiGLO Reagen and 20×
Pe oxide om Cell Signaling Technology, acco ding o manu ac u e ’s
ecommenda ions. En ichmen o mi ochond ial memb anes, solubilisa ion
o mi ochond ial complexes and BNE we e ca ied ou as desc ibed (Wi ig
e al., 2006; Heidle e al., 2013). Mi ochond ial complexes we e s ained
wi h Coomassie Blue (Wi ig e al., 2006) and speci ic in-gel his ochemical
s aining o cI, cIV, and cV was pe o med as desc ibed p e iously (Wi ig
e al., 2007). Fo immunode ec ion, BNE-gels we e blo ed on o PVDF
memb anes and p obed wi h an ibodies agains AOX (1:50,000) o
mi ochond ial complexes (Mi oP o ile To al OXPHOS Roden WB
An ibody Cock ail, Mi osciences, ab110413, 1:250) and cIV (1:1000;
Heidle e al., 2013).
Me abolomics
Me aboli e analysis was conduc ed as desc ibed p e iously (Nikkanen e al.,
2016), using skele al muscle om six hemizygous AOX
Rosa26
and six wild-
ype li e ma e con ol mice (8-week-old males, all culled a a single ime in
he mo ning). B ie ly, a ge ed me abolomics was implemen ed by ul a-
pe o mance liquid ch oma og aphy andem mass-spec ome y using a
Wa e s XEVO-TQ-S mass spec ome e . Me aboli es ex ac ed wi h
ace oni ile we e sepa a ed by hyd ophilic liquid-in e ac ion
ch oma og aphy, hen analysed spec ome ically by mul iple eac ion
moni o ing. Raw da a we e collec ed and analysed wi h Ta ge Lynx
so wa e (Wa e s), and me aboli es quan i ied using in e nal s anda ds and
calib a ion cu es. Fo ull de ails, see supplemen a y Ma e ials and
Me hods.
Bioene ge ic expe imen s
Fo espi ome y o mi ochond ia om di e en issues, mice we e
eu hanised by ce ical disloca ion and o gans we e dissec ed and collec ed
in o ice-cold PBS. So issues we e ine chopped (1 mm
3
) in ice-cold PBS
and hand-homogenized in 3 ml e-suspension bu e [225 mM suc ose,
75 mM D-manni ol, 10 mM T is/HCl, 1 mM EGTA, 1 mg/ml bo ine se um
albumin (BSA), pH 7.4], using a glass- e lon homogenize ( igh - i ing
pes le). Ha d issues (hea , skele al muscle and kidney), chopped o a simila
size, we e p e- ea ed wi h 3 ml (∼10 olumes) ice-cold ypsin-EDTA
[500 μg/ml ypsin (Di co), 0.5 mM EDTA, 10 μg/ml phenol ed, pH 7.4] o
10 min, ollowed by blocking wi h 300 μl oe al bo ine se um (Gibco/Li e
Technologies) and eco e y by low-speed cen i uga ion (40 g
max
,1min,4°
C) be o e homogeniza ion. Homogena es we e cen i uged a 1300 g
max
o
5 min a 4°C, a e which supe na an s we e collec ed and e-cen i uged a
17,000 g
max
o 15 min a 4°C. The mi ochond ial pelle was esuspended,
acco ding o i s size, in 75-250 μl ice-cold MiR05 bu e [0.5 mM EGTA,
3 mM MgCl
2
, 60 mM lac obionic acid (Ald ich, bu e ed o pH 7.0 wi h 5 M
KOH), 20 mM au ine (Sigma), 10 mM KH
2
PO
4
, 20 mM HEPES/KOH,
110 mM suc ose and 1 g/l a y-acid ee BSA (Sigma), pH 7.2 a oom
empe a u e] and s o ed on ice un il espi ome y. Mi ochond ial p o ein
con en was assayed using B ad o d eagen (Bio-Rad). Respi ome y, using
an O2K oxyg aph (O obo os), was conduc ed in MiR05 bu e in a 2 ml
chambe , o which was added 50 o 100 µg o mi ochond ia acco ding o he
issue. Subs a es and inhibi o s we e added in he ollowing o de : (1) 5 mM
sodium py u a e+5 mM sodium glu ama e+5 mM sodium mala e, (2) 4 mM
ADP, (3) 150 nM o enone (Sigma), (4) 17 mM sodium succina e, (5)
22.5 ng/ml an imycin A (Sigma), (6) 200 µM n-p opyl galla e (nPG, Sigma),
(7) 0.5 mM N,N,N′,N′- e ame hyl-p-phenylenediamine (TMPD, Sigma)
+2 mM sodium L-asco ba e, (8) 100 mM NaN
3
o 1 mM KCN. The lux
alues [pmol/(s×ml)] ob ained om he ace we e no malized o he amoun
o mi ochond ial p o ein. Fo measu emen s o ROS p oduc ion, mouse hea
mi ochond ia we e isola ed essen ially as desc ibed (Mela and Sei z, 1979),
wi h mino modi ica ions: issue was minced in 225 mM manni ol, 20 mM
MOPS, 75 mM suc ose, 1 mM EGTA, 0.5 mM di hio h e ol, pH 7.4 and
hand-homogenized in 10 ml/g issue o he same bu e con aining 0.05%
Naga se (Sigma). A e addi ion o 30 ml o he o iginal bu e , he
homogena e was cen i uged a 2000 g
max
o 4 min a 4°C. The supe na an
was passed h ough cheeseclo h and e-cen i uged a 12,000 g
max
o 10 min.
The esul ing pelle was esuspended in 225 mM manni ol, 20 mM MOPS,
75 mM suc ose, 0.1 mM EGTA, 75 mM KCl, pH 7.4. Mi ochond ial p o ein
con en was de e mined using he bicinchoninic acid assay (Wiechelman
e al., 1988), wi h BSA as s anda d. ROS p oduc ion unde condi ions used
o espi ome y was measu ed luo ime ically using 5 µM Amplex Red
(Hyd ogen Pe oxide Assay Ki , The mo Fishe Scien i ic) and 3 uni s/ml
ho se adish pe oxidase a 30°C, using a Ca y Eclipse luo ime e (Va ian)
wi h exci a ion a 560 nm and de ec ion a 590 nm (Zhou e al., 1997).
Mouse pheno yping
Mouse body weigh was measu ed using a small elec onic balance sui able
o oden s. G ip s eng h was measu ed using he BIO-GS3 appa a us
(Bioseb). Mice we e placed on he pla o m un il all ou limbs we e
engaged on he g id, and hen pulled o measu e he o ce gene a ed. The
mean o h ee measu emen s was no malised o body weigh (g/g) o each
animal es ed. All animals we e ained o h ee successi e days be o e he
ac ual expe imen . Endu ance unning was measu ed as p e iously (Ya suga
and Suomalainen, 2012), as he un ime on a s anda d unning bel (Exe -
6M T eadmill, Columbus Ins umen s), se o each a speed o 6.5 m/min in
s eps o 0.5 m/min e e y 3 min. A s ay o mo e han 5 s on he elec i ied
mo i a ion g id (0.5 mA cu en ) was conside ed as he end poin o
each es . Ca diac pa ame e s (ejec ion ac ion, le en icula mass)
we e de e mined by echoca diog aphy (Ve o 2100 sys em, FujiFilm
VisualSonics Inc.) o , whe e indica ed in igu e legends, by magne ic
esonance imaging (MRI), pe o med essen ially as desc ibed elsewhe e
(Zieba e al., 2008). MRI da a we e analysed using Osi iX Imaging
So wa e (h p://www.osi ix- iewe .com/index.h ml). Comp ehensi e
pheno yping by he Ge man Mouse Clinic (GMC) was conduc ed using
he p o ocols desc ibed and e e enced a h ps://www.mouseclinic.de
(sea ch ‘phenomap’). In all es s, mouse geno ypes we e blinded o he
expe imen e and e i ied subsequen ly.
Sys emic adminis a ion o cyanide
The p ocedu e was implemen ed unde con ac by Lu ia Scien i ic
Indus ies, He zliya, Is ael ( esponsible scien is D I is Maimon). Mice,
whose geno ypes we e blinded o he expe imen e , we e anes he ized wi h
3% iso lu ane in an induc ion chambe , a e which anaes hesia was
main ained by 2% iso lu ane using a nose cone. Co e empe a u e was kep
a 36.5°C using a hea ing pad. KCN was dissol ed in dis illed wa e a
10 mg/ml and deli e ed by IP injec ion o he mice a 8.5 mg/kg. Animals
we e obse ed o 48 h o he onse o dea h, de ined as apnea wi hou
u he espi a o y e o o mo emen o palpable ca diac pulsa ion.
E hical pe mi s
All mouse b eeding and expe imen s we e app o ed by he na ional e hical
commi ee in Finland, unde pe mi s ESAVI/8766/04.10.07/2015 and ESAVI/
169
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
2954/04.10.07/2015. Mouse expe imen s conduc ed unde con ac by Lu ia
Scien i ic Indus ies we e app o ed by IACUC unde assu ance 7433J45,
07/22/2015. Main enance o mice in Magdebu g was in acco d wi h p ocedu es
speci ied by he Animal Heal hand Ca e Commi eeso he O o- on-Gue icke
Uni e si y, Magdebu g, and o he S a e o Sachsen-Anhal , Ge many.
Image p ocessing
Images we e op imized o b igh ness and con as and c opped o cla i y.
No o he manipula ions such as gamma co ec ions we e made, no was any
ele an in o ma ion excluded by c opping. Full, o iginal gel images a e
a ailable on eques .
Acknowledgemen s
We hank Maa i Myo
ha
nen, Sonja K u
ge , Susanne K eu ze , Bi gi Spi znagel
and Jana Meis e knech o excellen echnical assis ance, Ch is ophe Ca oll,
Giuseppe Cannino, Luca Gio dano, Riikka Ki ela
and Uwe Rich e o echnical
ad ice and help, Anu Suomalainen and B endan Ba e sby, o use ul discussions,
and T oy Fai h ull o c i ical eading o he manusc ip .
Compe ing in e es s
The au ho s decla e no compe ing o inancial in e es s.
Au ho con ibu ions
H.T.J., T.B., P.R. and M.S. join ly concei ed he p ojec and de eloped he s a egy o
c ea e he AOX
Rosa26
mouse. M.S. supe ised and coo dina ed he labo a o y wo k,
which was conduc ed by M.S., P.K.D., E.D., K.M.H., Y.Z., I.S., I.W., J.H., Z.G., T.G.,
J.N., V.V., A.W. and F.N.G. H.F., V.G.-D. and M.H.d.A. implemen ed comp ehensi e
pheno yping in collabo a ion wi h hei colleagues om he Ge man Mouse Clinic.
H.T.J. compiled he manusc ip and igu es wi h assis ance om all au ho s.
Funding
This wo k was suppo ed by unding om he Eu opean Resea ch Council
(Ad anced G an 232738 o H.T.J.), Academy o Finland (Suomen Aka emia)
Te eyden Tu kimuksen Toimikun a (g an 272376); Tampe e Uni e si y
(Tampe een Yliopis o) Hospi al Medical Resea ch Fund; he Sig id Juselius
Founda ion (Sig id Juseliuksen Sa
a
 io
), Max-Planck-Gesellscha , Deu sche
Fo schungsgemeinscha (DFG SFB 815 p ojec Z1 o I.W. and DFG SFB 1213
p ojec A2 o T.B.), he Clus e o Excellence “Mac omolecula Complexes”, Goe he-
Uni e si a
 F ank u am Main, Ge many ( o I.W.), he Clus e o Excellence
“Ca diopulmona y Sys em”( o T.B.), he Ge man Cen e o Lung Resea ch (DLZ),
and he Uni e si ies o Helsinki and Tampe e (Helsingin Yliopis o and Tampe een
Yliopis o). This wo k has also been unded by he Ge man Fede al Minis y o
Educa ion and Resea ch (Bundesminis e ium u
 Bildung und Fo schung) o he
Ge man Mouse Clinic (In a on ie g an 01KX1012).
Da a a ailabili y
Comp ehensi e pheno yping by he Ge man Mouse Clinic (GMC) was conduc ed
using he p o ocols desc ibed and e e enced a h ps://www.mouseclinic.de (sea ch
‘phenomap’).
Supplemen a y in o ma ion
Supplemen a y in o ma ion a ailable online a
h p://dmm.biologis s.o g/lookup/doi/10.1242/dmm.027839.supplemen al
Re e ences
Acı

n-Pe ez, R., Fe nandez-Sil a, P., Pelea o, M. L., Pe ez-Ma os, A. and
En iquez, J. A. (2008). Respi a o y ac i e mi ochond ial supe complexes. Mol.
Cell 32, 529-539.
Bana es, S., Zeh, K., K ajewska, M., Ke me , P., Ba ibaul , H., Reed, J. C. and
K ajewski, S. (2005). No el pan-neu onal C e- ansgenic line o condi ional
abla ion o genes in he ne ous sys em. Genesis 42, 6-16.
Cas o-Gue e o, N. A., K ab, K. and Mo eno-Sanchez, R. (2004). The al e na i e
espi a o y pa hway o euglena mi ochond ia. J. Bioene g. Biomemb . 36,
459-469.
Chaban, Y., Boekema, E. J. and Dudkina, N. V. (2014). S uc u es o mi ochond ial
oxida i e phospho yla ion supe complexes and mechanisms o hei
s abilisa ion. Biochim. Biophys. Ac a 1837, 418-426.
Chen, C. M., K ohn, J., Bha acha ya, S. and Da ies, B. (2011). A compa ison o
exogenous p omo e ac i i y a he ROSA26 locus using a PhiC31 in eg ase
media ed casse e exchange app oach in mouse ESCs. PLoS ONE 6, e23376.
Chouchani, E. T., Pell, V. R., Gaude, E., Aksen ije ic, D., Sundie , S. Y., Robb,
E. L., Logan, A., Nad ochiy, S. M., O d, E. N. J., Smi h, A. C. e al. (2014).
Ischaemic accumula ion o succina e con ols epe usion inju y h ough
mi ochond ial ROS. Na u e 515, 431-435.
Dassa, E. P., Du ou , E., Gonçal es, S., Paupe, V., Hakkaa , G. A. J., Jacobs,
H. T. and Rus in, P. (2009). Exp ession o he al e na i e oxidase complemen s
cy och ome c oxidase de iciency in human cells. EMBO Mol. Med. 1, 30-36.
Delaunay, D., Heydon, K., Miguez, A., Schwab, M., Na e, K.-A., Thomas, J. L.,
Spassky, N., Ma inez, S. and Zalc, B. (2009). Gene ic acing o subpopula ion
neu ons in he p e halamus o mice (Mus musculus). J. Comp. Neu ol. 512, 74-83.
El-Khou y, R., Du ou , E., Rak, M., Ramanan soa, N., G andchamp, N., Csaba,
Z., Du illie, B., Beni , P., Gallego, J., G essens, P. e al. (2013). Al e na i e
oxidase exp ession in he mouse enables bypassing cy och ome c oxidase
blockade and limi s mi ochond ial ROS o e p oduc ion. PLoS Gene . 9,
e1003182.
El-Khou y, R., Kemppainen, K. K., Du ou , E., Szibo , M., Jacobs, H. T. and
Rus in, P. (2014). Enginee ing he al e na i e oxidase gene o be e unde s and
and coun e ac mi ochond ial de ec s: s a e o he a and pe spec i es.
B . J. Pha macol. 171, 2243-2249.
El-Khou y, R., Kaulio, E., Lassila, K. A., C ow he , D. C., Jacobs, H. T. and
Rus in, P. (2016). Exp ession o he al e na i e oxidase mi iga es be a-amyloid
p oduc ion and oxici y in model sys ems. F ee Radic. Biol. Med. 96, 57-66.
Fe nandez-Ayala, D. J. M., Sanz, A., Va iainen, S., Kemppainen, K. K.,
Babusiak, M., Mus alah i, E., Cos a, R., Tuomela, T., Ze iani, M., Chung, J.
e al. (2009). Exp ession o he Ciona in es inalis al e na i e oxidase (AOX) in
D osophila complemen s de ec s in mi ochond ial oxida i e phospho yla ion. Cell
Me ab. 9, 449-460.
F ied ich, G. and So iano, P. (1991). P omo e aps in emb yonic s em cells: a
gene ic sc een o iden i y and mu a e de elopmen al genes in mice. Genes De .
5, 1513-1523.
Hakkaa , G. A. J., Dassa, E. P., Jacobs, H. T. and Rus in, P. (2006). Allo opic
exp ession o a mi ochond ial al e na i e oxidase con e s cyanide esis ance o
human cell espi a ion. EMBO Rep. 7, 341-345.
Heidle , J., S ecke , V., Csin alan, F., Bleie , L. and Wi ig, I. (2013).
Quan i ica ion o p o ein complexes by blue na i e elec opho esis. Me hods
Mol. Biol. 1033, 363-379.
Hi oshi, N., Ken-ichi, Y. and Jun-ichi, M. (1991). E icien selec ion o high-
exp ession ans ec an s wi h a no el euka yo ic ec o . Gene 108, 193-199.
Hi z, C., Wu s , W. and Ku
hn, R. (2007). Condi ional b ain-speci ic knockdown o
MAPK using C e/loxP egula ed RNA in e e ence. Nucleic Acids Res. 35, e90.
Hoe nagel, M. H. N. and Wiskich, J. T. (1998). Ac i a ion o he plan al e na i e
oxidase by high educ ion le els o he Q-pool and py u a e. A ch. Biochem.
Biophys. 355, 262-270.
Humph ey, D. M., Pa sons, R. B., Ludlow, Z. N., Riemenspe ge , T., Esposi o,
G., Ve s eken, P., Jacobs, H. T., Bi man, S. and Hi h, F. (2012). Al e na i e
oxidase escues mi ochond ia-media ed dopamine gic cell loss in D osophila.
Hum. Mol. Gene . 21, 2698-2712.
Ida-Hosonuma, M., Iwasaki, T., Taya, C., Sa o, Y., Li, J., Naga a, N., Yonekawa,
H. and Koike, S. (2002). Compa ison o neu opa hogenici y o polio i us in wo
ansgenic mouse s ains exp essing human polio i us ecep o wi h di e en
dis ibu ion pa e ns. J. Gen. Vi ol. 83, 1095-1105.
Kemppainen, K. K., Rinne, J., S i am, A., Lakanmaa, M., Zeb, A., Tuomela, T.,
Popples one, A., Singh, S., Sanz, A., Rus in, P. e al. (2014). Exp ession o
al e na i e oxidase in D osophila amelio a es di e se pheno ypes due o
cy och ome oxidase de iciency. Hum. Mol. Gene . 23, 2078-2093.
Kim, H. S., Joo, H. J., Woo, J. S., Choi, Y. S., Choi, S. H., Kim, H. and Moon, W. K.
(2013). In i o magne ic esonance imaging o ansgenic mice exp essing human
e i in. Mol. Imaging Biol. 15, 48-57.
Koe sie , P. A., Scho , J. and Doe le , W. (1993). A apid op imized p o ocol o
downwa d alkaline Sou he n blo ing o DNA. Bio echniques 15, 260-262.
Liu, P., Jenkins, N. A. and Copeland, N. G. (2003). A highly e icien
ecombinee ing-based me hod o gene a ing condi ional knockou mu a ions.
Genome Res. 13, 476-484.
Liu, Y., Fu, S., Niu, R., Yang, C. and Lin, J. (2014). T ansc ip ional ac i i y
assessmen o h ee di e en p omo e s o mouse in u e o elec opo a ion
sys em. Plasmid 74, 52-58.
McDonald, A. E., Vanle be ghe, G. C. and S aples, J. F. (2009). Al e na i e
oxidase in animals: unique cha ac e is ics and axonomic dis ibu ion. J. Exp. Biol.
212, 2627-2634.
Mela, L. and Sei z, S. (1979). Isola ion o mi ochond ia wi h emphasis on hea
mi ochond ia om small amoun s o issue. Me hods Enzymol. 55, 39-46.
Mills, E. L., Kelly, B., Logan, A., Cos a, A. S. H., Va ma, M., B yan , C. E.,
Tou lomousis, P., Da
b i z, J. H. M., Go lieb, E. , La o e I. e al. (2016).
Succina e dehyd ogenase suppo s me abolic epu posing o mi ochond ia o
d i e in lamma o y mac ophages. Cell 167, 457-470.
Nikkanen, J., Fo ss o
m, S., Eu o, L., Pae au, I., Kohnz, R. A., Wang, L., Chilo ,
D., Viinama
ki, J., Roi ainen, A., Ma jama
ki, P. e al. (2016). Mi ochond ial DNA
eplica ion de ec s dis u b cellula dNTP pools and emodel one-ca bon
me abolism. Cell Me ab. 23, 635-648.
Nyabi, O., Naessens, M., Haigh, K., Gemba ska, A., Goossens, S., Mae ens, M.,
De Cle cq, S., D oga , B., Haenebalcke, L., Ba unko a, S. e al. (2009).
E icien mouse ansgenesis using Ga eway-compa ible ROSA26 locus a ge ing
ec o s and F1 hyb id ESCs. Nucleic Acids Res. 37, e55.
170
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms
Rei e , R. J., Manches e , L. C. and Tan, D. X. (2010). Neu o oxins: ee adical
mechanisms and mela onin p o ec ion. Cu . Neu opha macol. 8, 194-210.
Rod ı

guez, C. I., Buchholz, F., Galloway, J., Seque a, R., Kaspe , J., Ayala, R.,
S ewa , A. F. and Dymecki, S. M. (2000). High-e iciency dele e mice show ha
FLPe is an al e na i e o C e-loxP. Na . Gene . 25, 139-140.
Rus in, P. and Jacobs, H. T. (2009). Respi a o y chain al e na i e enzymes as ools
o be e unde s and and coun e ac espi a o y chain de iciencies in human cells
and animals. Physiol. Plan . 137, 362-370.
Samb ook, J., F i sch, E. F. and Mania is, T. (1989). Molecula Cloning: A
Labo a o y Manual. New Yo k, USA: Cold Sp ing Ha bo Labo a o y P ess.
So iano, P. (1999). Gene alized lacZ exp ession wi h he ROSA26 C e epo e
s ain. Na . Gene . 21, 70-71.
S ini as, S., Wa anabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M.
and Cos an ini, F. (2001). C e epo e s ains p oduced by a ge ed inse ion o
EYFP and ECFP in o he ROSA26 locus. BMC De . Biol. 1,4.
Vogel, F., Bo nho
 d, C., Neupe , W. and Reiche , A. S. (2006). Dynamic
subcompa men aliza ion o he mi ochond ial inne memb ane. J. Cell. Biol. 175,
237-247.
Wa ming, S., Cos an ino, N., Cou , D. L., Jenkins, N. A. and Copeland, N. G.
(2005). Simple and highly e icien BAC ecombinee ing using galK selec ion.
Nucleic Acids Res. 33, e36.
Wiechelman, K. J., B aun, R. D. and Fi zpa ick, J. D. (1988). In es iga ion o he
bicinchoninic acid p o ein assay: iden i ica ion o he g oups esponsible o colo
o ma ion. Anal. Biochem. 175, 231-237.
Wi ig, I., B aun, H.-P. and Scha
gge , H. (2006). Blue na i e PAGE. Na . P o oc. 1,
418-428.
Wi ig, I., Ka as, M. and Scha
gge , H. (2007). High esolu ion clea na i e
elec opho esis o in-gel unc ional assays and luo escence s udies o
memb ane p o ein complexes. Mol. Cell. P o eomics 6, 1215-1225.
Yamamo o, H. (1995). E ec o a opine on cyanide-induced acu e le hali y in mice.
Toxicol. Le . 80, 29-33.
Yamamo o, H. and Tang, H. W. (1996). An agonis ic e ec o mela onin agains
cyanide-induced seizu es and acu e le hali y in mice. Toxicol Le . 87, 19-24.
Ya suga, S. and Suomalainen, A. (2012). E ec o beza ib a e ea men on la e-
onse mi ochond ial myopa hy in mice. Hum. Mol. Gene . 21, 526-535.
Young, L., Shiba, T., Ha ada, S., Ki a, K., Albu y, M. S. and Moo e, A. L. (2013).
The al e na i e oxidases: simple oxido educ ase p o eins wi h complex unc ions.
Biochem. Soc. T ans. 41, 1305-1311.
Zamb owicz, B. P., Imamo o, A., Fie ing, S., He zenbe g, L. A., Ke , W. G. and
So iano, P. (1997). Dis up ion o o e lapping ansc ip s in he ROSA be a geo 26
gene ap s ain leads o widesp ead exp ession o be a-galac osidase in mouse
emb yos and hema opoie ic cells. P oc. Na l. Acad. Sci. USA 94, 3789-3794.
Zhang, D., Lee, B., Nu e , A., Song, P., Dola abadi, N., Pa ke , J., Sanz-Blasco,
S., Newmeye , T., Ambasudhan, R., McKe che , S. R. e al. (2015). P o ec ion
om cyanide-induced b ain inju y by he N 2 ansc ip ional ac i a o ca nosic
acid. J. Neu ochem. 133, 898-908.
Zhou, M., Diwu, Z., Panchuk-Voloshina, N. and Haugland, R. P. (1997). A s able
non luo escen de i a i e o eso u in o he luo ome ic de e mina ion o ace
hyd ogen pe oxide: applica ions in de ec ing he ac i i y o phagocy e NADPH
oxidase and o he oxidases. Anal. Biochem. 253, 162-168.
Zieba , T., Yoon, C.-H., T epels, T., Wie elmann, A., B aun, T., Kiessling, F.,
S ein, S., G ez, M., Ihling, C., Muhly-Reinholz, M.e al. (2008). Sus ained
pe sis ence o ansplan ed p oangiogenic cells con ibu es o neo ascula iza ion
and ca diac unc ion a e ischemia. Ci c. Res. 103, 1327-1334.
171
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 163-171 doi:10.1242/dmm.027839
Disease Models & Mechanisms